Murphy Nicole — SEC Form 4 filings
SEC reporting owner CIK 1910644. 9 Form 4 filings on record with FilingPulse; latest filed 2026-02-17.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2024-01-31 to 2026-02-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 3 shares, $585 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 38.
- Largest priced transaction: purchase of 3 shares @ $195.03 ($585) in BIOGEN INC., filed 2026-02-17.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| BIOGEN INC. (BIIB) | Head of Pharm Ops and Tech | 9 | 1 leg · 3 sh · $585 | — | 38 |
Form 4 filings — Murphy Nicole
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-02-17 | 4 | BIOGEN INC. (BIIB) | Purchase (P): 3 @ $195.03 · Grant/award (A): 10,560 (derivative) @ $0 | EDGAR |
| 2026-02-10 | 4 | BIOGEN INC. (BIIB) | Option exercise (M): 2,102 @ $0 · Tax withholding (F): 1,017 @ $201.18 · Option exercise (M): 1,940 @ $0 · Tax withholding (F): 914 @ $201.18 · Option exercise (M): 4,683 @ $0 · Tax withholding (F): 1,408 @ $201.18 · +3 more | EDGAR |
| 2025-02-12 | 4 | BIOGEN INC. (BIIB) | Option exercise (M): 2,272 @ $0 · Tax withholding (F): 670 @ $142.54 · Option exercise (M): 2,272 (derivative) @ $0 | EDGAR |
| 2025-02-10 | 4 | BIOGEN INC. (BIIB) | Option exercise (M): 2,102 @ $0 · Tax withholding (F): 620 @ $141.35 · Option exercise (M): 1,940 @ $0 · Tax withholding (F): 603 @ $141.35 · Grant/award (A): 14,050 (derivative) @ $0 · Option exercise (M): 2,102 (derivative) @ $0 · +1 more | EDGAR |
| 2024-04-03 | 4 | BIOGEN INC. (BIIB) | Option exercise (M): 240 @ $0 · Tax withholding (F): 117 @ $214.83 · Option exercise (M): 240 (derivative) @ $0 | EDGAR |
| 2024-02-21 | 4 | BIOGEN INC. (BIIB) | Option exercise (M): 856 @ $0 · Tax withholding (F): 414 @ $219.08 · Option exercise (M): 404 @ $0 · Tax withholding (F): 196 @ $219.08 · Option exercise (M): 856 (derivative) @ $0 · Option exercise (M): 404 (derivative) @ $0 · +1 more | EDGAR |
| 2024-02-13 | 4 | BIOGEN INC. (BIIB) | Option exercise (M): 2,272 @ $0 · Tax withholding (F): 761 @ $240.98 · Option exercise (M): 2,272 (derivative) @ $0 | EDGAR |
| 2024-02-09 | 4 | BIOGEN INC. (BIIB) | Option exercise (M): 2,101 @ $0 · Tax withholding (F): 638 @ $240.30 · Grant/award (A): 5,820 (derivative) @ $0 · Option exercise (M): 2,101 (derivative) @ $0 | EDGAR |
| 2024-01-31 | 4 | BIOGEN INC. (BIIB) | Grant/award (A): 856 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1910644 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →